Export 2971 results:
Author Title Type [ Year(Asc)]
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching., J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
D. - D. Zhang, Ou, Y. - N., Fu, Y., Wang, Z. - B., Huang, L. - Y., Tan, L., and Yu, J. - T., Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies., J Alzheimers Dis, vol. 89, no. 1, pp. 367-380, 2022.
H. Kim, Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., and Goldberg, T. E., The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks., J Alzheimers Dis, vol. 87, no. 4, pp. 1567-1580, 2022.
R. Piccarducci, Caselli, M. Chiara, Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., and Martini, C., The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy., J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials., J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial., J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging., J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
Y. Peng, Zhang, L., Zhou, F., Wang, Y., Zhang, X., Fan, J., Li, S., Li, X., and Li, Y., Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells., J Alzheimers Dis, vol. 90, no. 1, pp. 185-198, 2022.
P. Kundu, Zimmerman, B., Quinn, J. F., Kaye, J., Mattek, N., Westaway, S. K., and Raber, J., Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function., J Alzheimers Dis, vol. 86, no. 3, pp. 1471-1481, 2022.
A. Sil, Erfani, A., Lamb, N., Copland, R., Riedel, G., and Platt, B., Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model., J Alzheimers Dis, vol. 85, no. 2, pp. 755-778, 2022.
F. Rahmani, Wang, Q., McKay, N. S., Keefe, S., Hantler, N., Hornbeck, R., Wang, Y., Hassenstab, J., Schindler, S., Xiong, C., Morris, J. C., Benzinger, T. L. S., and Raji, C. A., Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity., J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
S. Hannonen, Andberg, S., Kärkkäinen, V., Rusanen, M., Lehtola, J. - M., Saari, T., Korhonen, V., Hokkanen, L., Hallikainen, M., Hänninen, T., Leinonen, V., Kaarniranta, K., Bednarik, R., and Koivisto, A. M., Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
A. E. Weller, Ferraro, T. N., Doyle, G. A., Reiner, B. C., Crist, R. C., and Berrettini, W. H., Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology., J Alzheimers Dis, vol. 90, no. 3, pp. 1233-1247, 2022.
C. Tong Lio, Kacprowski, T., Klaedtke, M., Jensen, L. R., Bouter, Y., Bayer, T. A., and Kuss, A. W., Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease., J Alzheimers Dis, vol. 87, no. 4, pp. 1671-1681, 2022.
J. M. Walker, Dehkordi, S. Kazempour, Schaffert, J., Goette, W., Iii, C. L. White, Richardson, T. E., and Zare, H., The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals., J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
D. Aschwanden, Sutin, A. R., Ledermann, T., Luchetti, M., Stephan, Y., Sesker, A. A., Zhu, X., and Terracciano, A., Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies., J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
J. M. Nolan, Power, R., Howard, A. N., Bergin, P., Roche, W., Prado-Cabrero, A., Pope, G., Cooke, J., Power, T., and Mulcahy, R., Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease., J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
C. F. M. Huffels, van Dijk, R. E., Karst, H., Meye, F. J., Hol, E. M., and Middeldorp, J., Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1., J Alzheimers Dis, vol. 89, no. 1, pp. 283-297, 2022.
J. Lynn, Park, M., Ogunwale, C., and Acquaah-Mensah, G. K., A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
G. Eastman, Sharlow, E. R., Lazo, J. S., Bloom, G. S., and Sotelo-Silveira, J. R., Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice., J Alzheimers Dis, vol. 86, no. 1, pp. 365-386, 2022.
M. M. Mielke, Ransom, J. E., Mandrekar, J., Turcano, P., Savica, R., and Brown, A. W., Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population., J Alzheimers Dis, vol. 88, no. 3, pp. 1049-1059, 2022.
R. McGrath, Robinson-Lane, S. G., Klawitter, L., Rhee, Y., Hamm, J. M., McCourt, M. E., Parker, K., and Hackney, K. J., Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults., J Alzheimers Dis, vol. 89, no. 2, pp. 473-482, 2022.
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C., Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
V. Fleming, Helsel, B. C., Ptomey, L. T., H Rosas, D., Handen, B., Laymon, C., Christian, B. T., Head, E., Mapstone, M., Lai, F., Krinsky-McHale, S., Zaman, S., Ances, B. M., Lee, J. H., and Hartley, S. L., Weight Loss and Alzheimer's Disease in Down Syndrome., J Alzheimers Dis, vol. 91, no. 3, pp. 1215-1227, 2022.